• Home
  • About the VALIANT Study
  • Site Locations & Contact
  • Understanding Clinical Research
  • English
  • Español
  • English
  • Español
  • English

VALIANT: A clinical research study for young people and adults with C3G or MPGN

VALIANT is a clinical research study evaluating the safety and effectiveness of an investigational medication in young people and adults with C3G (primary C3 glomerulopathy) or IC-MPGN (immune complex membranoproliferative glomerulonephritis).

Find a Participating Research Site
Find a Participating Research Site

VALIANT: A clinical research study for young people and adults with C3G or MPGN

VALIANT is a clinical research study evaluating the safety and effectiveness of an investigational medication in young people and adults with C3G (primary C3 glomerulopathy) or IC-MPGN (immune complex membranoproliferative glomerulonephritis).

  • Home
  • About the VALIANT Study
  • Site Locations & Contact
  • Understanding Clinical Research
  • Privacy Policy
  • Cookies
  • www.theVALIANTstudy.com
  • The VALIANT STUDY and the VALIANT STUDY logo are trademarks of Apellis Pharmaceuticals, Inc. Other trademarks referenced herein are the property of their respective owners. ©2022 Apellis Pharmaceuticals, Inc. All rights reserved. 08/21 - MED-US-PEGC3G-21-00001 v4.0